Clinical observation of different doses of rituximab for the treatment of severe pemphigus: A single-center prospective cohort study

J Am Acad Dermatol. 2023 Feb;88(2):500-502. doi: 10.1016/j.jaad.2022.06.1187. Epub 2022 Jun 30.
No abstract available

Keywords: anti-CD20; autoimmune bullous disease; pemphigus; prospective cohort; rituximab; treatment.

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Humans
  • Immunologic Factors / therapeutic use
  • Pemphigus* / drug therapy
  • Prospective Studies
  • Rituximab / therapeutic use

Substances

  • Rituximab
  • Immunologic Factors
  • Antibodies, Monoclonal